FI944961A0 - Farmaceutiskt preparat och förfarande för dess framställning - Google Patents

Farmaceutiskt preparat och förfarande för dess framställning

Info

Publication number
FI944961A0
FI944961A0 FI944961A FI944961A FI944961A0 FI 944961 A0 FI944961 A0 FI 944961A0 FI 944961 A FI944961 A FI 944961A FI 944961 A FI944961 A FI 944961A FI 944961 A0 FI944961 A0 FI 944961A0
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutical
prepn
clodronate
dissolves
Prior art date
Application number
FI944961A
Other languages
English (en)
Finnish (fi)
Other versions
FI110667B (sv
FI944961A (sv
Inventor
Juhani Posti
Kirsi Katila
Pertti Rantala
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to FI944961A priority Critical patent/FI110667B/sv
Publication of FI944961A0 publication Critical patent/FI944961A0/sv
Publication of FI944961A publication Critical patent/FI944961A/sv
Application granted granted Critical
Publication of FI110667B publication Critical patent/FI110667B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI944961A 1992-04-24 1994-10-21 Förfarande för framställning av ett farmaceutiskt preparat FI110667B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI944961A FI110667B (sv) 1992-04-24 1994-10-21 Förfarande för framställning av ett farmaceutiskt preparat

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning
PCT/FI1993/000166 WO1993021907A1 (en) 1992-04-24 1993-04-21 Pharmaceutical preparation and process for its manufacture
FI944961A FI110667B (sv) 1992-04-24 1994-10-21 Förfarande för framställning av ett farmaceutiskt preparat

Publications (3)

Publication Number Publication Date
FI944961A0 true FI944961A0 (sv) 1994-10-21
FI944961A FI944961A (sv) 1994-10-21
FI110667B FI110667B (sv) 2003-03-14

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944961A FI110667B (sv) 1992-04-24 1994-10-21 Förfarande för framställning av ett farmaceutiskt preparat

Country Status (21)

Country Link
US (1) US5525354A (sv)
EP (1) EP0637236B1 (sv)
JP (1) JP3536106B2 (sv)
AT (1) ATE143802T1 (sv)
AU (1) AU671830B2 (sv)
CA (1) CA2134196C (sv)
CZ (1) CZ282871B6 (sv)
DE (2) DE69305335T2 (sv)
DK (1) DK0637236T3 (sv)
EE (1) EE03107B1 (sv)
ES (1) ES2094539T3 (sv)
FI (1) FI110667B (sv)
GR (1) GR3022249T3 (sv)
HK (1) HK13097A (sv)
HU (1) HU219342B (sv)
IL (1) IL105403A (sv)
NO (1) NO306654B1 (sv)
RU (1) RU2116074C1 (sv)
SE (1) SE501389C2 (sv)
TW (1) TW273515B (sv)
WO (1) WO1993021907A1 (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
CZ287984B6 (cs) † 1993-05-15 2001-03-14 Roche Diagnostics Gmbh Tableta se zlepšenou biodostupností účinné látky, kyseliny klodronové, a způsob její výroby
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (sv) * 1993-11-12 1995-11-27 Leiras Oy Förfarande för framställning av ett klodronatpreparat
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (sv) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroral formulation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
CA2363123C (en) * 1999-02-22 2011-09-06 Kenneth Iain Cumming Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
JP4489356B2 (ja) 2001-05-11 2010-06-23 メリオン リサーチ スリー リミテッド 浸透促進剤
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
ES2426445T3 (es) 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
TW200950801A (en) 2008-05-07 2009-12-16 Merrion Res Iii Ltd Compositions of peptides and processes of preparation thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
EP0637236B1 (en) 1996-10-09
CA2134196C (en) 2004-02-10
NO944001L (no) 1994-10-21
IL105403A0 (en) 1993-08-18
CA2134196A1 (en) 1993-11-11
JP3536106B2 (ja) 2004-06-07
EE03107B1 (et) 1998-08-17
US5525354A (en) 1996-06-11
HU9403067D0 (en) 1994-12-28
DE69305335T2 (de) 1997-04-30
FI110667B (sv) 2003-03-14
HUT74572A (en) 1997-01-28
AU3955093A (en) 1993-11-29
NO306654B1 (no) 1999-12-06
HK13097A (en) 1997-02-14
CZ261494A3 (en) 1995-02-15
HU219342B (en) 2001-03-28
DE69305335D1 (de) 1996-11-14
WO1993021907A1 (en) 1993-11-11
DE637236T1 (de) 1995-07-06
SE9201299D0 (sv) 1992-04-24
EP0637236A1 (en) 1995-02-08
AU671830B2 (en) 1996-09-12
SE9201299L (sv) 1993-10-25
IL105403A (en) 1998-03-10
SE501389C2 (sv) 1995-01-30
DK0637236T3 (da) 1997-03-17
TW273515B (sv) 1996-04-01
FI944961A (sv) 1994-10-21
NO944001D0 (no) 1994-10-21
RU2116074C1 (ru) 1998-07-27
CZ282871B6 (cs) 1997-11-12
ES2094539T3 (es) 1997-01-16
JPH07505898A (ja) 1995-06-29
RU94045950A (ru) 1996-11-10
GR3022249T3 (en) 1997-04-30
ATE143802T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
FI944961A0 (sv) Farmaceutiskt preparat och förfarande för dess framställning
FI950319A (sv) Morfinpreparat med reglerad frigöringshastighet
ES2144077T3 (es) Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
ES2062417T3 (es) Composiciones farmaceuticas de cimetidina.
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
FI960851A (sv) Förfarande för framställningen av N-amino-1-hydroxi-alkyliden-1,1-bisfosfonsyror
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
ATE321538T1 (de) Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
IT1285079B1 (it) Sistema attuatore per la compensazione dell'allineamento di una macchina.
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
CA2057456A1 (en) Anti depression pharmaceutical
IS4288A (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi
ITBO920325A1 (it) Sistema computerizzato per la gestione clinica-chirurgica di un paziente in ambito odontoiatrico.